Pad Chivukula's Net Worth
$28.6 Million
Who is Pad Chivukula?
Pad Chivukula has an estimated net worth of $28.6 Million. This is based on reported shares across multiple companies, which include Arcturus Therapeutics Holdings Inc., and Arcturus Therapeutics Ltd..
SEC CIK
Pad Chivukula's CIK is 0001727317
Past Insider Trading and Trends
2019 was Pad Chivukula's most active year for acquiring shares with 2 total transactions. Pad Chivukula's most active month to acquire stocks was the month of January. 2023 was Pad Chivukula's most active year for disposing of shares, totalling 12 transactions. Pad Chivukula's most active month to dispose stocks was the month of April. 2019 saw Pad Chivukula paying a total of $199,600.00 for 40,000 shares, this is the most they've acquired in one year. In 2020 Pad Chivukula cashed out on 40,000 shares for a total of $2,394,600.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcturus Therapeutics Holdings Inc. (ARCT) Snapshot price: $37.33
Chief Scientific Officer & COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.03% | -114.00 |
$45.00 | -$5,130.00 | 447.33K |
Scheduled
|
Jun 5
| ||
Form 4
| -5.49% | -26.00K |
$40.01 | -$1,040,234.00 | 447.45K |
Scheduled
|
Jun 3
| ||
Form 4
| -3.55% | -17.43K |
$35.02 | -$610,573.70 | 473.45K |
Scheduled
|
Mar 25
| ||
Form 4
| -1.71% | -8.56K |
$35.01 | -$299,839.24 | 490.88K |
Scheduled
|
Mar 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| -0.99% | -5.00K |
$18.72 | -$93,601.50 | 499.45K |
Scheduled
|
Nov 1
| ||
Form 4
| -0.98% | -5.00K |
$25.61 | -$128,061.50 | 504.45K |
Oct 2
| |||
Form 4
| -0.97% | -5.00K |
$31.45 | -$157,263.50 | 509.45K |
Sep 1
| |||
Form 4
| -0.96% | -5.00K |
$34.91 | -$174,550.00 | 514.45K |
Aug 1
| |||
Form 4
| -4.59% | -25.00K |
$35.01 | -$875,250.00 | 519.45K |
Jul 14
| |||
Form 4
| -0.91% | -5.00K |
$28.75 | -$143,750.00 | 544.45K |
Jul 3
| |||
Form 4
| -0.90% | -5.00K |
$27.16 | -$135,800.00 | 549.45K |
Jun 1
| |||
Form 4
| -4.31% | -25.00K |
$30.08 | -$751,902.00 | 554.45K |
May 10 - May 11
| |||
Form 4
| -0.86% | -5.00K |
$25.93 | -$129,650.00 | 579.45K |
May 1
| |||
Form 4
| -0.85% | -5.00K |
$25.38 | -$126,900.00 | 584.45K |
Apr 3
| |||
Form 4
| -0.84% | -5.00K |
$16.07 | -$80,350.00 | 589.45K |
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| -1.34% | -8.10K |
$40.00 | -$324,000.00 | 594.45K |
Scheduled
|
Jan 4
| ||
Form 4
| -0.60% | -3.63K |
$40.00 | -$145,327.63 | 602.55K |
Scheduled
|
Dec 16
| ||
Form 4
| -1.04% | -6.37K |
$40.00 | -$254,680.00 | 606.18K |
Scheduled
|
Dec 8
| ||
Form 4
| -1.61% | -10.00K |
$44.41 | -$444,100.00 | 612.55K |
Scheduled
|
Nov 1
| ||
Form 4
| -1.58% | -10.00K |
$44.36 | -$443,600.00 | 622.55K |
Scheduled
|
Oct 1
| ||
Form 4
| -1.56% | -10.00K |
$55.86 | -$558,600.00 | 632.55K |
Scheduled
|
Sep 1
| ||
Form 4
| -1.53% | -10.00K |
$40.07 | -$400,700.00 | 642.55K |
Scheduled
|
Aug 3
| ||
Form 4
| -1.51% | -10.00K |
$42.95 | -$429,500.00 | 652.55K |
Scheduled
|
Apr 1
| ||
Form 4
| -1.49% | -10.00K |
$54.23 | -$542,300.00 | 662.55K |
Scheduled
|
Mar 1
| ||
Form 4
| -1.47% | -10.00K |
$75.31 | -$753,100.00 | 672.55K |
Scheduled
|
Feb 1
| ||
Form 4
| -1.44% | -10.00K |
$46.40 | -$464,000.00 | 682.55K |
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| -1.42% | -10.00K |
$96.19 | -$961,900.00 | 692.55K |
Scheduled
|
Dec 1
| ||
Form 4
| -1.40% | -10.00K |
$55.28 | -$552,800.00 | 702.55K |
Scheduled
|
Nov 2
| ||
Form 4
| -1.38% | -10.00K |
$42.83 | -$428,300.00 | 712.55K |
Scheduled
|
Oct 1
| ||
Form 4
| -1.37% | -10.00K |
$45.16 | -$451,600.00 | 722.55K |
Scheduled
|
Sep 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
| No matching records found | |||||||||
Arcturus Therapeutics Ltd. No price found
Chief Scientific Officer & COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||